304 A probiotic yeast-based immunotherapy against Clostridioides difficile infection.
https://stm.sciencemag.org/content/12/567/eaax4905
303 Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments.
https://www.medrxiv.org/content/10.1101/2020.10.15.20209817v1
302 Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
https://www.pnas.org/content/117/41/25897
301 Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
https://www.pnas.org/content/117/41/25237
300 Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.
https://www.nature.com/articles/s41586-020-2575-3
299 Hydroxychloroquine is not useful against SARS-CoV-2 infection in non-human primates.
https://www.nature.com/articles/s41586-020-2558-4
298 A network-based explanation of why most COVID-19 infection curves are linear.
https://www.pnas.org/content/117/37/22684
297 The nucleotide analogue prodrug remdesivir reduces viral load and lung disease in a rhesus macaque model of SARS-CoV-2 infection.
https://www.nature.com/articles/s41586-020-2423-5
296 Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
https://science.sciencemag.org/content/369/6508/1210
295 Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.
https://science.sciencemag.org/content/369/6508/eabc8511
294 COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis.
https://www.nature.com/articles/s41587-020-0602-4
293 The implications of silent transmission for the control of COVID-19 outbreaks.
https://www.pnas.org/content/117/30/17513
292 Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report.
https://www.nejm.org/doi/full/10.1056/NEJMoa2021436?query=featured_home
291 Single-dose baloxavir showed significant postexposure prophylactic efficacy in preventing influenza in household contacts of patients with influenza.
https://www.nejm.org/doi/full/10.1056/NEJMoa1915341?query=featured_home
290 Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis.
https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(20)30289-4
289 Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
https://www.nejm.org/doi/full/10.1056/NEJMoa1916046?query=featured_home
288 Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
https://www.nejm.org/doi/full/10.1056/NEJMoa1912400?query=featured_home
287 A mobile app, the COVID Symptom Study, offers data on risk factors, early symptoms, clinical outcomes, and geographical hotspots.
https://science.sciencemag.org/content/368/6497/1362
286 Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States.
https://www.cell.com/cell/fulltext/S0092-8674(20)30484-0
285 Remdesivir for the Treatment of Covid-19 — Preliminary Report.
https://www.nejm.org/doi/full/10.1056/NEJMoa2007764?query=featured_home
|
